<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2023.1310057</article-id><article-id pub-id-type="publisher-id">WJCD-128411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  ECG and Echocardiographic Findings of Female Hypertension (fHTN) in the Cardiology Department of the University Hospital Gabriel Tour&#233; (UH-GT)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamidou</surname><given-names>Oumar Bâ</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahima</surname><given-names>Sangaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Youssouf</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kassim</surname><given-names>Kamaté</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tawoufik</surname><given-names>Tchedre</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Georges</surname><given-names>Rosario Christian Millogo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djénébou</surname><given-names>Traoré</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Noumou</surname><given-names>Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fousseyni</surname><given-names>Samassékou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Massama</surname><given-names>Konaté</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Coumba</surname><given-names>Thiam Doumbia</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Asmaou</surname><given-names>Maiga</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Réné-Marie</surname><given-names>Dakouo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamidou</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adama</surname><given-names>Sogodogo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boubacar</surname><given-names>Diarra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Touré</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boubacar</surname><given-names>Sonfo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aladji</surname><given-names>Traoré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Diakité</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ilo</surname><given-names>Bella Diall</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ichaka</surname><given-names>Menta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Cardiology, University Hospital Yalgado Ouédraogo, Ouagadougou, Burkina-Faso</addr-line></aff><aff id="aff2"><addr-line>Cardiology, University Hospital Sidy Bocar Sall, Kati, Mali</addr-line></aff><aff id="aff5"><addr-line>Cardiology, University Hospital “H&amp;amp;ocirc;pital du Mali”, Bamako, Mali</addr-line></aff><aff id="aff6"><addr-line>Cardiology, University Hospital Mother-Children, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Internal Medecine, University Hospital Point G, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Cardiology, University Hospital Gabriel Touré, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>10</month><year>2023</year></pub-date><volume>13</volume><issue>10</issue><fpage>646</fpage><lpage>656</lpage><history><date date-type="received"><day>28,</day>	<month>August</month>	<year>2023</year></date><date date-type="rev-recd"><day>17,</day>	<month>October</month>	<year>2023</year>	</date><date date-type="accepted"><day>20,</day>	<month>October</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: 
  In our setting there is a lack of publications on female hypertension in general population motivating this study to look for electro- and echocardiographic findings of female hypertension. <b>Methods: </b>We performed a cross-sectional study during 6 months in the cardiology department of the UH-GT including 324 female patients aged 18 and more seen in the outpatient unit and by whom the diagnosis of hypertension was set. All patients consented to be study participants after receiving clearly information about the study and that care giving will not be affected by their eventual refusal. Data collection has been done with all needed confidentiality rules. A survey formular was used to collect data in order to record them in an Access database. Analysis was done using IBM SPSS software. Quantitative data are presented as mean with standard deviation and qualitative as proportion. Level of significance for statistic test was set at 5%. <b>Results: </b>During the study time 324 among 524 hypertensive patients visited our outpatient unit giving a prevalence of fHTN of 61.8%. The means for age, body mass index (BMI) in female hypertensive patients were respectively 52 &#177; 14.461 years and 27.35 &#177; 06.585 Kg/m<sup>2</sup>. Main ECG findings were left ventricular hypertrophy (LVH) and sinus tachycardia with respectively 93
  .
  6% and 46.4% followed by isolated ventricular extrasystole with 33.7%. Echocardiography findings included LVH, relative wall thickness (RWT) and reduced ejection fraction (EF) in respectively 41.05
  %
  , 37.35
  %
   and 21.91%. The left ventricular mass (LV) mass and geometry were abnormal in 44.4% and 37.3%. Remodeling as geometry modification (18.2%) and mitral flow Type 2 (90.4%) have been the most abnormal findings. <b>Conclusion: </b>Hypertension induced modifications mainly LVH in ECG and Echocardiography in female patients less than encountered among male hypertensive patients.
 
</p></abstract><kwd-group><kwd>Hypertension</kwd><kwd> Female</kwd><kwd> ECG</kwd><kwd> Echocardiography</kwd><kwd> Mali</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardiovascular diseases (CVDs) are the leading cause of death globally with an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths [<xref ref-type="bibr" rid="scirp.128411-ref1">1</xref>] . And also prevalent cases of total CVD nearly doubled from in 1990 to 523 million in 2019 [<xref ref-type="bibr" rid="scirp.128411-ref2">2</xref>] . Among all others risk factors, including lipid abnormalities, tobacco smoking, physical inactivity, high salt consumption, arterial hypertension (HTN) is the most important contributor to the global burden of these diseases [<xref ref-type="bibr" rid="scirp.128411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref5">5</xref>] . It is an important public-health challenge worldwide [<xref ref-type="bibr" rid="scirp.128411-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref9">9</xref>] . There is also a shift of HTN from high-income countries to low-income countries in south Asia and sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.128411-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref11">11</xref>] and variable declines in hypertension has been noted in Europe [<xref ref-type="bibr" rid="scirp.128411-ref12">12</xref>] . Both female and male are affected with female prevalence of up to 83% [<xref ref-type="bibr" rid="scirp.128411-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref15">15</xref>] .</p><p>In African countries HTN is a public-health problem [<xref ref-type="bibr" rid="scirp.128411-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref19">19</xref>] and also for female with variable prevalence of 46.8% in Nigeria and 13.7% in Kenya [<xref ref-type="bibr" rid="scirp.128411-ref20">20</xref>] . There are many studies on hypertension in pregnancy [<xref ref-type="bibr" rid="scirp.128411-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref23">23</xref>] . In our setting publication is lack on fHTN in general population motivating this study to look for electro- and echocardiographic findings of female hypertension.</p></sec><sec id="s2"><title>2. Methods</title><p>We performed a cross-sectional study from November 2022 to April 2023 in the cardiology department of the UH-GT.</p><p>Included were female patients aged 18 and more seen in the outpatient unit and by whom the diagnosis of hypertension was set.</p><p>Definition of terms:</p><p>Hypertension has been defined as patient with systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg or patient being under anti-hypertensive therapy.</p><p>For ECG left ventricular hypertrophy (LVH) was assessed through Sokolow-Lyon voltage (SV1 + RV5 or V6 ≥ 35 mV) and Cornell voltage (SV3 + RaVL &gt; 20 mV).</p><p>Left ventricular (LV) mass and relative wall thickness (RWT) were calculated in accordance with the American Society of Echocardiography convention using the following corrected equations:</p><p>- LV mass (g) = 0.80 &#215; 1.04 [(LV end-diastolic diameter + septal wall thickness + posterior wall thickness)<sup>3</sup> – (LV end-diastolic diameter)<sup>3</sup>] + 0.6 [<xref ref-type="bibr" rid="scirp.128411-ref24">24</xref>] .</p><p>- RWT = (septal wall thickness + posterior wall thickness)/LV end-diastolic diameter [<xref ref-type="bibr" rid="scirp.128411-ref25">25</xref>] .</p><p>Echocardiographic left ventricular hypertrophy (LVH) was defined as a LV mass index (LVMI: LV mass/body surface area) &gt; 150 g/m<sup>2</sup> in men and &gt;120 g/m<sup>2</sup> in women.</p><p>All patients consented to be study participants after receiving clear information about the study and that care giving will not be affected by their eventual refusal. Data collection has been done with all needed confidentiality rules.</p><p>A survey formular was used to collect data in order to record them in an Access database. Analysis was done using IBM SPSS software. Quantitative data are presented as mean with standard deviation and qualitative as proportion. Level of significance for statistic test was set at 5%.</p></sec><sec id="s3"><title>3. Results</title><p>During the study time 324 among 524 hypertensive patients visited our outpatient unit giving a prevalence of female hypertension of 61.8%.</p><p>The proportion of patients increased with age from 06.5 for &lt;30 years to 35.5% in the age group &gt; 60 years, 54% of the sample were new patients. Among old patients less than a third was regularly followed or treated with respectively 31.8% and 20.7% (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The means for age, body mass index (BMI) were respectively 52 &#177; 14.461 years and 27.35 &#177; 06.585 Kg/m<sup>2</sup>. According to the American Society of Echocardiography mean left ventricular mass and relative wall thickness were respectively 176 g and 0.4 (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>ECG has been found abnormal in 49.1% of all cases. It’s main findings were hypertrophy followed by rhythm disorders with respectively 29.1 and 21.91%. Conduction and repolarization disorders were found with less cases (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Hypertrophy signs were dominated by left ventricular hypertrophy (LVH) with 93.6%. Among rhythm disorders sinus tachycardia came with 46.4% followed by isolated ventricular extrasystole with 33.7%. Conduction disorders were dominated by left bundle branch block (LBBB) (45.4%) whereas hypertrophy was found in 19.1% with LVH represented in 93.6% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Echocardiography findings included LVH, relative wall thickness (RWT) and reduced ejection fraction (EF) has been found in respectively 41.05%, 37.35% and 21.91% (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The LV mass and geometry were abnormal in 44.4% and 37.3%. Remodeling as geometry modification (18.2%) and mitral flow Type 2 (90.4%) have been the most abnormal findings (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic and clinical characteristics of the sample of 324 hypertensive female patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >(%)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="4"  >Age group (years)</td><td align="center" valign="middle" >&lt;30</td><td align="center" valign="middle" >021</td><td align="center" valign="middle" >06.5</td></tr><tr><td align="center" valign="middle" >30 - 44</td><td align="center" valign="middle" >079</td><td align="center" valign="middle" >24.4</td></tr><tr><td align="center" valign="middle" >45 - 59</td><td align="center" valign="middle" >109</td><td align="center" valign="middle" >33.6</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >35.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Type</td><td align="center" valign="middle" >New</td><td align="center" valign="middle" >175</td><td align="center" valign="middle" >54.0</td></tr><tr><td align="center" valign="middle" >Old</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >46.0</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Regularity</td><td align="center" valign="middle" >Visit</td><td align="center" valign="middle" >103</td><td align="center" valign="middle" >31.8</td></tr><tr><td align="center" valign="middle" >Treatment</td><td align="center" valign="middle" >066</td><td align="center" valign="middle" >20.4</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Number of molecules</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >215</td><td align="center" valign="middle" >66.4</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >067</td><td align="center" valign="middle" >20.7</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >036</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >006</td><td align="center" valign="middle" >01.9</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >BMI* class (317 patients)</td><td align="center" valign="middle" >Underweight</td><td align="center" valign="middle" >011</td><td align="center" valign="middle" >03.5</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >133</td><td align="center" valign="middle" >42.0</td></tr><tr><td align="center" valign="middle" >Overweight</td><td align="center" valign="middle" >079</td><td align="center" valign="middle" >24.9</td></tr><tr><td align="center" valign="middle" >Obesity</td><td align="center" valign="middle" >094</td><td align="center" valign="middle" >29.7</td></tr></tbody></table></table-wrap><p>* Body mass index for 317 patients.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of variables in the sample of 324 hypertensive female patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Min</th><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >Max</th><th align="center" valign="middle" >SD</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >14.461</td></tr><tr><td align="center" valign="middle" >Height (cm)</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >164</td><td align="center" valign="middle" >188</td><td align="center" valign="middle" >06.452</td></tr><tr><td align="center" valign="middle" >Weight (Kg)</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >131</td><td align="center" valign="middle" >18.095</td></tr><tr><td align="center" valign="middle" >BMI (Kg/m<sup>2</sup>)</td><td align="center" valign="middle" >13.84</td><td align="center" valign="middle" >27.35</td><td align="center" valign="middle" >58.22</td><td align="center" valign="middle" >06.585</td></tr><tr><td align="center" valign="middle" >DIVGd (mm)</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >49.2</td><td align="center" valign="middle" >84.6</td><td align="center" valign="middle" >00.827</td></tr><tr><td align="center" valign="middle" >PWd (mm)</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >9.7</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >00.214</td></tr><tr><td align="center" valign="middle" >IVSd (mm)</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >9.4</td><td align="center" valign="middle" >19.4</td><td align="center" valign="middle" >00.205</td></tr><tr><td align="center" valign="middle" >LV Mass (g) /Ase</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >176</td><td align="center" valign="middle" >610</td><td align="center" valign="middle" >70.197</td></tr><tr><td align="center" valign="middle" >LV Mass index (g/m<sup>2</sup>)</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >398</td><td align="center" valign="middle" >40.576</td></tr><tr><td align="center" valign="middle" >EF (%)</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >15.377</td></tr><tr><td align="center" valign="middle" >RWT</td><td align="center" valign="middle" >0.17</td><td align="center" valign="middle" >0.40</td><td align="center" valign="middle" >0.95</td><td align="center" valign="middle" >0.108</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> ECG findings in the sample of 324 hypertensive female patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >(%)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="6"  >Rhythm disorders</td><td align="center" valign="middle" >Sinus tachycardia</td><td align="center" valign="middle" >033</td><td align="center" valign="middle" >46.4</td></tr><tr><td align="center" valign="middle" >VES</td><td align="center" valign="middle" >024</td><td align="center" valign="middle" >33.7</td></tr><tr><td align="center" valign="middle" >Atrial fibrillation</td><td align="center" valign="middle" >009</td><td align="center" valign="middle" >12.6</td></tr><tr><td align="center" valign="middle" >SVT</td><td align="center" valign="middle" >002</td><td align="center" valign="middle" >02.8</td></tr><tr><td align="center" valign="middle" >VES + SVES</td><td align="center" valign="middle" >002</td><td align="center" valign="middle" >02.8</td></tr><tr><td align="center" valign="middle" >VES bigeminated</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.4</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Conduction disorders (11)</td><td align="center" valign="middle" >LBBB</td><td align="center" valign="middle" >005</td><td align="center" valign="middle" >45.4</td></tr><tr><td align="center" valign="middle" >RBBB</td><td align="center" valign="middle" >003</td><td align="center" valign="middle" >27.2</td></tr><tr><td align="center" valign="middle" >ALHB</td><td align="center" valign="middle" >002</td><td align="center" valign="middle" >18.1</td></tr><tr><td align="center" valign="middle" >AVB1 + LBBB</td><td align="center" valign="middle" >001</td><td align="center" valign="middle" >09.0</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Hypertrophy</td><td align="center" valign="middle" >LV</td><td align="center" valign="middle" >008</td><td align="center" valign="middle" >93.6</td></tr><tr><td align="center" valign="middle" >RV</td><td align="center" valign="middle" >003</td><td align="center" valign="middle" >03.1</td></tr><tr><td align="center" valign="middle" >LV + LA</td><td align="center" valign="middle" >002</td><td align="center" valign="middle" >02.1</td></tr><tr><td align="center" valign="middle" >LA</td><td align="center" valign="middle" >001</td><td align="center" valign="middle" >001</td></tr></tbody></table></table-wrap><p>VES: ventricular extrasystole; SVT: supra-ventricular tachycardia; SVES: supraventricular tachycardia; LBBB: left bundle branch block; RBBB: right bundle branch block; ALHB: anterior left hemi-block; AVB1: atrio-ventricular block first grade; LV: left ventricle; RV: right ventricle; LA: left atrium.</p></sec><sec id="s4"><title>4. Discussion</title><p>HTN as public-health problem need to be more addressed particularly in female patients as pointed out in this study with a prevalence of HTN 61.8%. The prevalence of fHTN varies greatly around the world with nearly 20% to 78% in some European regions [<xref ref-type="bibr" rid="scirp.128411-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref27">27</xref>] . Ours is higher than that of other African countries like Nigeria (46.8%) and Kenya (13.7%) and lower compared to Brazilian female (71.9%). This variation could be explained by the sample composition (general population, employers, hospitalized patients) and across different population.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Echocardiographic findings in the sample of 324 hypertensive female patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >(%)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >LVEF</td><td align="center" valign="middle" >≥50</td><td align="center" valign="middle" >253</td><td align="center" valign="middle" >78.1</td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >029</td><td align="center" valign="middle" >009</td></tr><tr><td align="center" valign="middle" >&lt;40</td><td align="center" valign="middle" >042</td><td align="center" valign="middle" >013</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >LV mass</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >180</td><td align="center" valign="middle" >55.6</td></tr><tr><td align="center" valign="middle" >Borderline</td><td align="center" valign="middle" >032</td><td align="center" valign="middle" >09.9</td></tr><tr><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >031</td><td align="center" valign="middle" >09.6</td></tr><tr><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >070</td><td align="center" valign="middle" >21.6</td></tr><tr><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >011</td><td align="center" valign="middle" >03.4</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >LV geometry</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >203</td><td align="center" valign="middle" >62.7</td></tr><tr><td align="center" valign="middle" >Concentric LVH</td><td align="center" valign="middle" >020</td><td align="center" valign="middle" >06.2</td></tr><tr><td align="center" valign="middle" >Excentric LVH</td><td align="center" valign="middle" >042</td><td align="center" valign="middle" >13.0</td></tr><tr><td align="center" valign="middle" >Remodeling</td><td align="center" valign="middle" >059</td><td align="center" valign="middle" >18.2</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Mitral flow</td><td align="center" valign="middle" >Type 1</td><td align="center" valign="middle" >020</td><td align="center" valign="middle" >06.2</td></tr><tr><td align="center" valign="middle" >Type 2</td><td align="center" valign="middle" >293</td><td align="center" valign="middle" >90.4</td></tr><tr><td align="center" valign="middle" >Type 3</td><td align="center" valign="middle" >011</td><td align="center" valign="middle" >03.4</td></tr></tbody></table></table-wrap><p>*ASE.</p><p>According to sex in our department female HTN is more prevalent than male HTN (38.2% of our hypertensive patients). Most studies found a more prevalent male HTN [<xref ref-type="bibr" rid="scirp.128411-ref27">27</xref>] particularly before menopause that disappears after menopause [<xref ref-type="bibr" rid="scirp.128411-ref28">28</xref>] .</p><p>In this HTN increases with age (<xref ref-type="table" rid="table1">Table 1</xref>) according to published data in the world and mostly due to vascular modifications with aging.</p><p>ECG:</p><p>HTN is strongly correlated to cardiovascular mortality [<xref ref-type="bibr" rid="scirp.128411-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref30">30</xref>] . A intermediate step is ECG and echocardiographic modifications and ECG as strong predictor of cardiovascular events [<xref ref-type="bibr" rid="scirp.128411-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref32">32</xref>] . ECG remains the first line method for LVH detection in patients with hypertension [<xref ref-type="bibr" rid="scirp.128411-ref33">33</xref>] despite it low sensibility [<xref ref-type="bibr" rid="scirp.128411-ref34">34</xref>] .</p><p>In this study ECG anomalies were found in near half of the sample. Data suggest that target organ damage is less common in female [<xref ref-type="bibr" rid="scirp.128411-ref35">35</xref>] . LVH is the most common ECG anomaly among hypertensive patients [<xref ref-type="bibr" rid="scirp.128411-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref37">37</xref>] .</p><p>Echocardiography:</p><p>Prevalence of echocardiographic LVH in our study was round 29%. In the literature LVH in echocardiography varies based on study population with most values higher than found in our study [<xref ref-type="bibr" rid="scirp.128411-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref39">39</xref>] . Variations could be also due to used parameters [<xref ref-type="bibr" rid="scirp.128411-ref40">40</xref>] , to sex with greater prevalence in men than in female [<xref ref-type="bibr" rid="scirp.128411-ref41">41</xref>] and finally to increase in blood pressure level [<xref ref-type="bibr" rid="scirp.128411-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.128411-ref43">43</xref>] or pulse pressure [<xref ref-type="bibr" rid="scirp.128411-ref44">44</xref>] .</p><p>Regarding LVH geometry we found concentric remodeling in accordance with most studies [<xref ref-type="bibr" rid="scirp.128411-ref25">25</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Hypertension induced modifications mainly LVH in ECG and Echocardiography in female patients less than encountered among male hypertensive patients.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>B&#226;, H.O., Sangar&#233;, I., Camara, Y., Kamat&#233;, K., Tchedre, T., Mil- logo, G.R.C., Traor&#233;, D., Sidib&#233;, N., Samass&#233;kou, F., Konat&#233;, M., Doumbia, C.T., Maiga, A., Dakouo, R.-M., Camara, H., Sogodogo, A., Diarra, B., Tour&#233;, M., Sonfo, B., Traor&#233;, A., Diakit&#233;, M., Diall, I.B. and Menta, I. (2023) ECG and Echocardiographic Findings of Female Hypertension (fHTN) in the Cardiology Department of the University Hospital Gabriel Tour&#233; (UH-GT). World Journal of Cardiovascular Diseases, 13, 646-656. https://doi.org/10.4236/wjcd.2023.1310057</p></sec></body><back><ref-list><title>References</title><ref id="scirp.128411-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2017) Maladies Cardiovasculaires. Cardiovascular Diseases (CVDs)  
https://www.who.int/fr/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)</mixed-citation></ref><ref id="scirp.128411-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019. Journal of the American College of Cardiology, 76, 2982-3021.  
https://doi.org/10.1016/j.jacc.2020.11.021</mixed-citation></ref><ref id="scirp.128411-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Brouwers, S., Sudano, I., Kokubo, Y. and Sulaica, E.M. (2021) Arterial Hypertension. The Lancet, 398, 249-261. https://doi.org/10.1016/S0140-6736(21)00221-X</mixed-citation></ref><ref id="scirp.128411-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cappuccio, F.P. and Miller, M.A. (2016) Cardiovascular Disease and Hypertension in Sub-Saharan Africa: Burden, Risk and Interventions. Internal and Emergency Medicine, 11, 299-305. https://doi.org/10.1007/s11739-016-1423-9</mixed-citation></ref><ref id="scirp.128411-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Franklin, S.S. and Wong, N.D. (2013) Hypertension and Cardiovascular Disease: Contributions of the Framingham Heart Study. Global Heart, 8, 49-57.  
https://doi.org/10.1016/j.gheart.2012.12.004</mixed-citation></ref><ref id="scirp.128411-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. and He, J. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. The Lancet, 365, 217-223. https://doi.org/10.1016/S0140-6736(05)17741-1</mixed-citation></ref><ref id="scirp.128411-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mills, K.T., Bundy, J.D., Kelly, T.N., Reed, J.E., Kearney, P.M., Reynolds, K., Chen, J. and He, J. (2015) Global Burden of Hypertension: Analysis of Population-Based Studies from 89 Countries. Journal of Hypertension, 33, e2.  
https://doi.org/10.1097/01.hjh.0000469726.59998.cc</mixed-citation></ref><ref id="scirp.128411-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ahern, D. and Dixon, E. (2015) Pediatric Hypertension: A Growing Problem. Primary Care: Clinics in Office Practice, 42, 143-150.  
https://doi.org/10.1016/j.pop.2014.09.003</mixed-citation></ref><ref id="scirp.128411-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Forouzanfar, M.H., Liu, P., Roth, G.A., Ng, M., Biryukov, S., Marczak, L., et al. (2017) Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA: The Journal of the American Medical Association, 317, 165-182.</mixed-citation></ref><ref id="scirp.128411-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">NCD Risk Factor Collaboration (NCD-RisC) (2018) Contributions of Mean and Shape of Blood Pressure Distribution to Worldwide Trends and Variations in Raised Blood Pressure: A Pooled Analysis of 1018 Population-Based Measurement Studies with 88.6 Million Participants. International Journal of Epidemiology, 47, 872-883.</mixed-citation></ref><ref id="scirp.128411-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mills, K.T., Stefanescu, A. and He, J. (2020) The Global Epidemiology of Hypertension. Nature Reviews Nephrology, 16, 223-237.  
https://doi.org/10.1038/s41581-019-0244-2</mixed-citation></ref><ref id="scirp.128411-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Timmis, A., Townsend, N., Gale, C.P., Torbica, A., Lettino, M., Petersen, S.E., et al. (2020) European Society of Cardiology: Cardiovascular Disease Statistics 2019. European Heart Journal, 41, 12-85.</mixed-citation></ref><ref id="scirp.128411-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ninios, I., Ninios, V., Lazaridou, F., Dimitriadis, K., Kerasidou, O. and Louridas, G. (2008) Gender-Specific Differences in Hypertension Prevalence, Treatment, Control, and Associated Conditions among the Elderly: Data from a Greek Population. Clinical and Experimental Hypertension, 30, 327-337.  
https://doi.org/10.1080/10641960802269943</mixed-citation></ref><ref id="scirp.128411-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Hoshino, J., Hori, Y., Kondo, T., Tamakoshi, K., Toyoshima, H. and Sakakibara, H. (2013) Characteristics of Hypertension-Related Factors in Female Home Caregivers in Japan—Comparison with General Community Non-Caregivers. Journal of Clinical Nursing, 22, 466-478. https://doi.org/10.1111/j.1365-2702.2011.04039.x</mixed-citation></ref><ref id="scirp.128411-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Abramson, B.L. and Melvin, R.G. (2014) Cardiovascular Risk in Women: Focus on Hypertension. Canadian Journal of Cardiology, 30, 553-559.  
https://doi.org/10.1016/j.cjca.2014.02.014</mixed-citation></ref><ref id="scirp.128411-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ataklte, F., Erqou, S., Kaptoge, S., Taye, B., Echouffo-Tcheugui, J.B. and Kengne, A.P. (2015) Burden of Undiagnosed Hypertension in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Hypertension, 65, 291-298.  
https://doi.org/10.1161/HYPERTENSIONAHA.114.04394</mixed-citation></ref><ref id="scirp.128411-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nulu, S., Aronow, W.S. and Frishman, W.H. (2016) Hypertension in Sub-Saharan Africa: A Contextual View of Patterns of Disease, Best Management, and Systems Issues. Cardiology in Review, 24, 30-40.  
https://doi.org/10.1097/CRD.0000000000000083</mixed-citation></ref><ref id="scirp.128411-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ba, H.O., Camara, Y., Menta, I., Sangaré, I., Sidibé, N., Diall, I.B., et al. (2018) Hypertension and Associated Factors in Rural and Urban Areas Mali: Data from the STEP 2013 Survey. International Journal of Hypertension, 2018, Article ID: 6959165.  
https://doi.org/10.1155/2018/6959165</mixed-citation></ref><ref id="scirp.128411-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Moloro, A.H., Seid, A.A. and Jaleta, F.Y. (2023) A Systematic Review and Meta-Analysis Protocol on Hypertension Prevalence and Associated Factors among Bank Workers in Africa. SAGE Open Medicine, 11, 1-8.  
https://doi.org/10.1177/20503121231172001</mixed-citation></ref><ref id="scirp.128411-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Meng, H.T. and Yue, J. (2018) A12014 Worldwide Prevalence of Female Hypertension: A Systematic Review. Journal of Hypertension, 36, e319.  
https://doi.org/10.1097/01.hjh.0000549304.69836.2f</mixed-citation></ref><ref id="scirp.128411-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Touré, I., Brah, F. and Prual, A. (1997) Hypertension Artérielle (Hta) Et Grossesse Au Niger: études Cas/Témoins à Propos de 70 Cas. Médecine d’Afrique Noire, 44, 205-208.</mixed-citation></ref><ref id="scirp.128411-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Baragou, S., Goeh-Akue, E., Pio, M., Afassinou, Y.M. and Atta, B. (2014) Hypertension artérielle et grossesse à Lomé (Afrique sub-saharienne): Aspects épidémiologiques, diagnostiques et facteurs de risque. Annales de Cardiologie et d’Angéiologie, 63, 145-150. https://doi.org/10.1016/j.ancard.2014.05.006</mixed-citation></ref><ref id="scirp.128411-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Allali-Nabitz, C., Lorthioir, A., Amar, L. and De Freminville, J.B. (2023) Prévalence de l’hypertension artérielle secondaire chez les femmes ayant un antécédent de pré-éclampsie. JMV-Journal de Médecine Vasculaire, 48, S43.  
https://doi.org/10.1016/j.jdmv.2022.12.037</mixed-citation></ref><ref id="scirp.128411-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Levy, D., Savage, D.D., Garrison, R.J., Anderson, K.M., Kannel, W.B. and Castelli, W.P. (1987) Echocardiographic Criteria for Left Ventricular Hypertrophy: The Framingham Heart Study. The American Journal of Cardiology, 59, 956-960.  
https://doi.org/10.1016/0002-9149(87)91133-7</mixed-citation></ref><ref id="scirp.128411-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ganau, A., Devereux, R.B., Roman, M.J., de Simone, G., Pickering, T.G., Saba, P.S., et al. (1992) Patterns of Left Ventricular Hypertrophy and Geometric Remodeling in Essential Hypertension. Journal of the American College of Cardiology, 19, 1550- 1558. https://doi.org/10.1016/0735-1097(92)90617-V</mixed-citation></ref><ref id="scirp.128411-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Trapaidze, D., Tsinamdzgvrishvili, B., Abesadze, T., Sharashidze, N., Shengelia, L. and Tsiklauri, K. (2015) P-131: Arterial Hypertension and Its Risk-Factors in Women Population. Annales de Cardiologie et d’Angéiologie, 64, S67-S68.  
https://doi.org/10.1016/S0003-3928(16)30175-5</mixed-citation></ref><ref id="scirp.128411-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Bachir Cherif, A., Bouamra, A., Taleb, A., Nedjar, R., Bouraghda, A., Hamida, F., et al. (2017) Differences in Prevalence, Treatment and Control Rates of Hypertension between Male and Female in the Area of Blida (Algeria). Annales de Cardiologie et d’Angéiologie, 66, 123-129. https://doi.org/10.1016/j.ancard.2017.04.009</mixed-citation></ref><ref id="scirp.128411-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Blacher, J., Kretz, S., Sorbets, E., Lelong, H., Vallée, A. and Lopez-Sublet, M. (2019) épidémiologie de l’HTA: Différences femme/homme. La Presse Médicale, 48, 1240- 1243. https://doi.org/10.1016/j.lpm.2019.04.010</mixed-citation></ref><ref id="scirp.128411-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R. and Prospective Studies Collaboration (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies. The Lancet, 360, 1903-1913.  
https://doi.org/10.1016/S0140-6736(02)11911-8</mixed-citation></ref><ref id="scirp.128411-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Lacey, B., Lewington, S., Clarke, R., Kong, X.L., Chen, Y., Guo, Y., et al. (2018) Age- Specific Association between Blood Pressure and Vascular and Non-Vascular Chronic Diseases in 0?5 Million Adults in China: A Prospective Cohort Study. The Lancet Global Health, 6, e641-e649. </mixed-citation></ref><ref id="scirp.128411-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Devereux, R.B., Koren, M.J., de Simone, G., Okin, P.M. and Kligfield, P. (1993) Methods for Detection of Left Ventricular Hypertrophy: Application to Hypertensive Heart Disease. European Heart Journal, 14, 8-15.  
https://doi.org/10.1093/eurheartj/14.suppl_D.8</mixed-citation></ref><ref id="scirp.128411-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Ang, D.S.C. and Lang, C.C. (2008) The Prognostic Value of the ECG in Hypertension: Where Are We Now? Journal of Human Hypertension, 22, 460-467.  
https://doi.org/10.1038/jhh.2008.24</mixed-citation></ref><ref id="scirp.128411-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Schillaci, G., Battista, F. and Pucci, G. (2012) A Review of the Role of Electrocardiography in the Diagnosis of Left Ventricular Hypertrophy in Hypertension. Journal of Electrocardiology, 45, 617-623. https://doi.org/10.1016/j.jelectrocard.2012.08.051</mixed-citation></ref><ref id="scirp.128411-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Pewsner, D., Jüni, P., Egger, M., Battaglia, M., Sundstrom, J. and Bachmann, L.M. (2007) Accuracy of Electrocardiography in Diagnosis of Left Ventricular Hypertrophy in Arterial Hypertension: Systematic Review. The BMJ, 335, Article 711.  
https://doi.org/10.1136/bmj.39276.636354.AE</mixed-citation></ref><ref id="scirp.128411-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Boivin, J.M., Koch, C., Vigié, L. and Meppiel, L. (2015) Prévalence de l’atteinte des organes cibles chez des patients traités pour une HTA: Comparaison homme/femme. étude ESSENTIELLE. Annales de Cardiologie et d’Angéiologie, 64, 150-157.  
https://doi.org/10.1016/j.ancard.2015.04.006</mixed-citation></ref><ref id="scirp.128411-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Lehtonen, A.O., Puukka, P., Varis, J., Porthan, K., Tikkanen, J.T., Nieminen, M.S., et al. (2016) Prevalence and Prognosis of ECG Abnormalities in Normotensive and Hypertensive Individuals. Journal of Hypertension, 34, 959-966.  
https://doi.org/10.1097/HJH.0000000000000882</mixed-citation></ref><ref id="scirp.128411-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">de Hartog-Keyzer, J.M.L., Messaoudi, S.E., Harskamp, R., Vart, P., Ringoir, L., Pop, V., et al. (2020) Electrocardiography for the Detection of Left Ventricular Hypertrophy in an Elderly Population with Long-Standing Hypertension in Primary Care: A Secondary Analysis of the CHELLO Cohort Study. BMJ Open, 10, e038824.  
https://doi.org/10.1136/bmjopen-2020-038824</mixed-citation></ref><ref id="scirp.128411-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Ruiz-Nodar, J.M., Puchades, R., Jiménez-Borreguero, J., Blanco, F., Rodríguez, F., Alonso, M., et al. (2008) Echocardiographic Findings in an Elderly Population. Influence of Arterial Hypertension. The Epicardian Study. Revista Espanola de Cardiología (English Edition), 61, 881-883.  
https://doi.org/10.1016/S1885-5857(08)60236-4</mixed-citation></ref><ref id="scirp.128411-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Mancusi, C., Angeli, F., Verdecchia, P., Poltronieri, C., De Simone, G. and Reboldi, G. (2019) Echocardiography in Low-Risk Hypertensive Patients. Journal of the American Heart Association, 8, e013497. https://doi.org/10.1161/JAHA.119.013497</mixed-citation></ref><ref id="scirp.128411-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Liebson, P.R., Grandits, G., Prineas, R., Dianzumba, S., Flack, J.M., Cutler, J.A., et al. (1993) Echocardiographic Correlates of Left Ventricular Structure among 844 Mildly Hypertensive Men and Women in the Treatment of Mild Hypertension Study (TOMHS). Circulation, 87, 476-486. https://doi.org/10.1161/01.CIR.87.2.476</mixed-citation></ref><ref id="scirp.128411-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, N., Kishida, Y., Ezumi, T., Murata, K., Hadano, Y., Akagawa, E., et al. (2006) 3142. Ultrasound in Medicine and Biology, 32, 215.  
https://doi.org/10.1016/j.ultrasmedbio.2006.02.912</mixed-citation></ref><ref id="scirp.128411-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Cuspidi, C., Sala, C., Tadic, M., Gherbesi, E., Grassi, G. and Mancia, G. (2018) Pre- Hypertension and Subclinical Cardiac Damage: A Meta-Analysis of Echocardiographic Studies. Journal of Hypertension, 36, e231.  
https://oce.ovid.com/article/00004872-201806001-00697/HTML  
https://doi.org/10.1097/01.hjh.0000539650.21350.42</mixed-citation></ref><ref id="scirp.128411-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Cuspidi, C., Facchetti, R., Bombelli, M., Tadic, M., Sala, C., Grassi, G., et al. (2019) High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings from the PAMELA Population. Hypertension, 73, 612-619.  
https://doi.org/10.1161/HYPERTENSIONAHA.118.12114</mixed-citation></ref><ref id="scirp.128411-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Pannier, B., Brunei, P., Aroussy, W.E., Lacolley, P. and Safar, M.E. (1989) Pulse Pressure and Echocardiographic Findings in Essential Hypertension. Journal of Hypertension, 7, 127-132. https://oce.ovid.com/article/00004872-198902000-00008/HTML</mixed-citation></ref></ref-list></back></article>